DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY;DAEWOONG PHARMACEUTICAL CO. LTD.
发明人:
OH, Sung-Yong,MIN, Kyung-Hyun,吳成容,閔庚鉉
申请号：
HK17105701.0
公开号：
HK1232128A
申请日:
2017.06.09
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
Provided is a method for preventing or treating skin rash comprising administering to a subject in need thereof epidermal growth factor as an active ingredient. The skin rash includes a skin disorder caused by administering an epidermal growth factor receptor inhibitor, such as erlotinib, as an adverse event.
